Minimally-Invasive Venogram for Intracranial Venous Hypertension
Trial Summary
What is the purpose of this trial?
The purpose of this research is to document normal intracranial venous sinus pressures. Participants who need to have a cerebral angiogram to evaluate a medical problem not related to Idiopathic Intracranial Hypertension (IIH) will be invited to participate. Participation in this research will not require any extra visits. The intervention will take place in the interventional radiology suite when the subject has an angiogram. IIH is a condition that causes increased pressure in the brain in the absence of a tumor or other diseases that may be causing symptoms. Symptoms include headaches and visual disturbances not explained by other things. In IIH there is a narrowing in the sinuses of the brain that causes the increased pressure.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Minimally-Invasive Venogram for Intracranial Venous Hypertension?
Research shows that cerebral venography and manometry can effectively identify venous hypertension (high pressure in the veins) in patients with idiopathic intracranial hypertension, which suggests that these techniques can help diagnose and manage conditions involving increased pressure in the brain's veins.12345
How is the minimally-invasive venogram treatment different from other treatments for intracranial venous hypertension?
The minimally-invasive venogram treatment is unique because it uses a special technique called venography combined with manometry to measure and address high pressure in the brain's veins, which is not well shown by other imaging methods. This approach is less invasive and potentially more accurate than traditional methods, making it a novel option for diagnosing and managing intracranial venous hypertension.12456
Research Team
Kyle Fargen, MD
Principal Investigator
Wake Forest University Health Sciences
Eligibility Criteria
This trial is for individuals who are scheduled for an elective cerebral angiogram and do not have a history of severe daily headaches, idiopathic intracranial hypertension, or a body mass index over 35. It excludes those with heart failure, pulmonary hypertension, intracranial venous pathology, or pregnancy due to radiation risks.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants undergo a standard cerebral angiogram followed by the study intervention involving additional catheter insertion and venogram
Follow-up
Participants are monitored for any immediate complications following the procedure
Treatment Details
Interventions
- Venogram
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wake Forest University Health Sciences
Lead Sponsor